Increased level of Tc17 and CD8+ IFN-γ+ TNF-α+ IL-17+ T cells in relapse phase highlights the critical role of IL-17 in RRMS pathogenesis. This evidence concerns the gene CD8A and relapsing-remitting multiple sclerosis.